Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (27)

« Back to Publications

Favipiravir for COVID-19 in adults in the community in PRINCIPLE, an open-label, randomised, controlled, adaptive platform trial of short- and longer-term outcomes

Hobbs FR. et al, (2024), Journal of Infection, 89

Ivermectin for COVID-19 in adults in the community (PRINCIPLE): An open, randomised, controlled, adaptive platform trial of short- and longer-term outcomes

Hayward G. et al, (2024), Journal of Infection, 88

Long-Term Blood Pressure Control After Hypertensive Pregnancy Following Physician-Optimized Self-Management The POP-HT Randomized Clinical Trial

Kitt J. et al, (2023), JAMA, 330, 1991 - 1999

Clinical diagnosis of SARS-CoV-2 infection: An observational study of respiratory tract infection in primary care in the early phase of the pandemic

van der Velden AW. et al, (2023), European Journal of General Practice, 29

Efficacy and safety of a modified vaccinia ankara-np+m1 vaccine combined with qiv in people aged 65 and older: A randomised controlled clinical trial (invictus)

Butler C. et al, (2021), Vaccines, 9

Is physician assessment of alcohol consumption useful in predicting risk of severe liver disease among people with HIV and HIV/HCV co-infection?

Shanyinde M. et al, (2019), BMC Public Health, 19

Incidence and predictors of single drug discontinuation according to the presence of HCV coinfection in HIV patients from the ICONA Foundation Cohort Study

Leone S. et al, (2018), European Journal of Clinical Microbiology and Infectious Diseases, 37, 871 - 881

HIV-1 co-receptor tropism and liver fibrosis in HIV-infected patients

Saracino A. et al, (2018), PLoS ONE, 13

Access and response to direct antiviral agents (DAA) in HIV-HCV co-infected patients in Italy: Data from the Icona cohort

Monforte ADA. et al, (2017), PLoS ONE, 12

Mobile Phone Text Messages to Support Treatment Adherence in Adults with High Blood Pressure (SMS-Text Adherence Support [StAR]): A Single-Blind, Randomized Trial

Bobrow K. et al, (2016), Circulation, 133, 592 - 600

Are HIV/HCV co-infected patients more likely to experience multiple lines of ART than HIV mono-infected patients? Results from the Icona Foundation study

Marchetti G. et al, (2016), JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 19

Is ART use associated with increased risk of ALT elevation in HIV/HCV co-infected patients over and above what is expected in HIV mono-infected? A nested case-control analysis

Shanyinde M. et al, (2016), JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 19

Patients with HIV-HBV coinfection are an underestimated reservoir for Hepatitis Delta Virus. An analysis of the ICONA cohort

Gaeta GB. et al, (2016), HEPATOLOGY, 64, 883A - 884A

A novel meningococcal outer membrane vesicle vaccine with constitutive expression of FetA: A phase I clinical trial

Marsay L. et al, (2015), Journal of Infection

A novel meningococcal outer membrane vesicle vaccine with constitutive expression of FetA: A phase I clinical trial

Marsay L. et al, (2015), Journal of Infection, 71, 326 - 337

Load More